These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3398709)

  • 21. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent.
    Baratti CM; Kopf SR
    Neurobiol Learn Mem; 1996 Mar; 65(2):121-4. PubMed ID: 8833101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oxotremorine and physostigmine on the inhibitory avoidance impairment produced by amitriptyline in male and female mice.
    Monleón S; Urquiza A; Vinader-Caerols C; Parra A
    Behav Brain Res; 2009 Dec; 205(2):367-71. PubMed ID: 19616041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of MK-801 stereoisomers on schedule-controlled behavior in rats.
    Genovese RF; Lu XC
    Psychopharmacology (Berl); 1991; 105(4):477-80. PubMed ID: 1771215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of chronic effects of diazepam on responding of rats under fixed-ratio schedules.
    Smith JB
    Eur J Pharmacol; 1999 Dec; 385(2-3):89-97. PubMed ID: 10607863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of principles of steady-state kinetics to the estimation of brain acetylcholine turnover rate: effects of oxotremorine and physostigmine.
    Trabucchi M; Cheney DL; Hanin I; Costa E
    J Pharmacol Exp Ther; 1975 Jul; 194(1):57-64. PubMed ID: 1151756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: evidence for a cholinergic mechanism.
    Stanford JA; Fowler SC
    Neurosci Lett; 1997 Apr; 225(3):157-60. PubMed ID: 9147394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cholinergic drugs on rat neocortical high-voltage spindles in ketanserin-treated rats.
    Jäkälä P; Björklund M; Koivisto E; Riekkinen P
    Eur J Pharmacol; 1996 Dec; 316(2-3):181-93. PubMed ID: 8982685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of barbiturates in rats tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Hardwick WC; Wells JD
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):4-14. PubMed ID: 6312913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of morphine tolerance by behavioral variables.
    Sannerud CA; Young AM
    J Pharmacol Exp Ther; 1986 Apr; 237(1):75-81. PubMed ID: 3958974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of physostigmine-induced changes in behavior.
    Gonzalez LP
    Pharmacol Biochem Behav; 1984 Oct; 21(4):551-4. PubMed ID: 6504953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dose order in the development of tolerance to effects of cocaine on schedule-controlled behavior in pigeons.
    Miller ML; Branch MN
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):302-9. PubMed ID: 12373431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.
    Pleuvry BJ; Tobias MA
    Br J Pharmacol; 1971 Dec; 43(4):706-14. PubMed ID: 4261560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of physostigmine on the accuracy and activity of discrimination behaviour in rats.
    Cox T
    Neuropharmacology; 1974 Aug; 13(8):701-5. PubMed ID: 4444756
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior.
    McMillan DE; Leander JD
    J Pharmacol Exp Ther; 1978 Nov; 207(2):515-20. PubMed ID: 712634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central muscarinic M2 cholinoceptors involved in cholinergic hypertension.
    Ozkutlu U; Onat F; Aslan AN; Oktay S
    Eur J Pharmacol; 1993 Dec; 250(3):349-54. PubMed ID: 8112394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of d- and l- amphetamine on fixed-interval and fixed-ratio behavior in tolerant and nontolerant rats.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):372-9. PubMed ID: 4748553
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurobehavioral toxicity of 2,4-D-n-butyl ester (2,4-D ester): tolerance and lack of cross-tolerance.
    Schulze GE; Dougherty JA
    Neurotoxicol Teratol; 1988; 10(1):75-9. PubMed ID: 3352572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.